Kezar Life Sciences, Inc. (KZR)
Pharmaceutical Preparations
Latest Price
$7.29
TTM P/E
--
Normalized P/E
--
Div Yield
--
Book Value
8.88
P/B Ratio
0.82
Institutional Ownership
58.7% held by institutions| Institution | Shares | Value | Ownership % | Change | Filing Date |
|---|---|---|---|---|---|
| BML Capital Management, LLC | 720.8K | $5.0M | 9.77% | -- | 2026-03-31 |
| MONTANOVA CAPITAL, LLC | 716.8K | $5.0M | 9.72% | -- | 2026-03-31 |
| TANG CAPITAL MANAGEMENT LLC | 664.3K | $4.0M | 9.01% | -- | 2026-03-31 |
| VANGUARD CAPITAL MANAGEMENT LLC | 290.5K | $2.0M | 3.94% | -- | 2026-03-31 |
| Rangeley Capital, LLC | 243.1K | $1.0M | 3.30% | +157.1K | 2026-03-31 |
| Affinity Asset Advisors, LLC | 229.1K | $1.0M | 3.11% | -- | 2026-03-31 |
| RENAISSANCE TECHNOLOGIES LLC | 188.4K | $1.0M | 2.56% | +57.1K | 2026-03-31 |
| MILLENNIUM MANAGEMENT LLC | 142.1K | $1.0M | 1.93% | +116.4K | 2026-03-31 |
| Peapod Lane Capital LLC | 126.7K | -- | 1.72% | -7 | 2026-03-31 |
| Ikarian Capital, LLC | 102.2K | -- | 1.39% | -- | 2026-03-31 |